Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
33
SNPS Quote, Financials, Valuation and Earnings
Last price:
$448.10
Seasonality move
:
11.46%
Day range:
$440.00 - $460.81
52-week range:
$425.73 - $624.80
Dividend yield:
0%
P/E ratio:
33.53x
P/S ratio:
11.66x
P/B ratio:
7.54x
Volume:
1.5M
Avg. volume:
1.3M
1-year change:
-17.55%
Market cap:
$70.1B
Revenue:
$6.1B
EPS (TTM):
$13.52
Analysts' Opinion
-
Consensus RatingSynopsys has received a consensus rating of Buy. The company's average rating is a Buy based on 15 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $625.25, Synopsys has an estimated upside of 37.87% from its current price of $453.51.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $520.00 representing 100% downside risk from its current price of $453.51.
Fair Value
-
According to the consensus of 16 analysts, Synopsys has 37.87% upside to fair value with a price target of $625.25 per share.
SNPS vs. S&P 500
-
Over the past 5 trading days, Synopsys has overperformed the S&P 500 by 4.1% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Synopsys does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Synopsys revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Synopsys reported revenues of $1.5B.
Earnings Growth
-
Synopsys earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Synopsys reported earnings per share of $1.89.
Enterprise value:
66.3B
EV / Invested capital:
7.12x
Price / LTM sales:
11.66x
EV / EBIT:
47.65x
EV / Revenue:
10.92x
PEG ratio (5yr expected):
0.69x
EV / Free cash flow:
50.87x
Price / Operating cash flow:
54.28x
Enterprise value / EBITDA:
39.67x
Gross Profit (TTM):
$4.8B
Return On Assets:
17.78%
Net Income Margin (TTM):
34.75%
Return On Equity:
26.4%
Return On Invested Capital:
26.34%
Operating Margin:
17.31%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Income Statement | ||||||
| Revenue | $4.7B | $5.6B | $6.1B | $1.5B | $1.5B | |
| Gross Profit | $3.8B | $4.5B | $4.8B | $1.2B | $1.2B | |
| Operating Income | $1.1B | $1.4B | $1.3B | $352.6M | $251.8M | |
| EBITDA | $1.3B | $1.7B | $1.7B | $521.7M | $349.7M | |
| Diluted EPS | $6.06 | $9.08 | $13.52 | $2.89 | $1.89 | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.4B | $2.9B | $3B | $3.4B | $6.3B | |
| Total Assets | $8B | $8.9B | $9.6B | $10.6B | $13B | |
| Current Liabilities | $2.2B | $2.5B | $2.7B | $2.6B | $2.4B | |
| Total Liabilities | $3.1B | $3.5B | $3.9B | $3.9B | $3.7B | |
| Total Equity | $4.9B | $5.4B | $5.7B | $6.7B | $9.3B | |
| Total Debt | $123.1M | $24.4M | $20.6M | $17M | $14.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.7B | $1.5B | $1.4B | -$87.8M | -$67.5M | |
| Cash From Investing | -$540.8M | -$500.3M | $1.3B | -$54.4M | -$22M | |
| Cash From Financing | -$1.1B | -$1B | -$136M | -$187.2M | -$141.8M | |
| Free Cash Flow | $1.6B | $1.3B | $1.3B | -$128.2M | -$108.2M | |
SNPS
Sector
Market Cap
$70.1B
$91.6M
Price % of 52-Week High
72.59%
60%
Dividend Yield
0%
0%
Shareholder Yield
-0.29%
0.82%
1-Year Price Total Return
-17.55%
-15.91%
Beta (5-Year)
1.156
0.910
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$442.00
200-day SMA
Sell
Level
$528.74
Bollinger Bands (100)
Sell
Level
475.95 - 545.21
Chaikin Money Flow
Buy
Level
424.5M
20-day SMA
Sell
Level
$465.54
Relative Strength Index (RSI14)
Sell
Level
44.16
ADX Line
Sell
Level
26.27
Williams %R
Neutral
Level
-55.3878
50-day SMA
Sell
Level
$494.91
MACD (12, 26)
Sell
Level
-18.69
25-day Aroon Oscillator
Sell
Level
-88
On Balance Volume
Neutral
Level
235.5M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (13.8978)
Buy
CA Score
(Annual)
Level (1.0105)
Buy
Beneish M-Score
(Annual)
Level (-2.3957)
Sell
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-3.4278)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys’ comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Stock Forecast FAQ
In the current month, SNPS has received 15 Buy ratings 1 Hold ratings, and 0 Sell ratings. The SNPS average analyst price target in the past 3 months is $625.25.
-
Where Will Synopsys Stock Be In 1 Year?
According to analysts, the consensus estimate is that Synopsys share price will rise to $625.25 per share over the next 12 months.
-
What Do Analysts Say About Synopsys?
Analysts are divided on their view about Synopsys share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Synopsys is a Sell and believe this share price will drop from its current level to $520.00.
-
What Is Synopsys's Price Target?
The price target for Synopsys over the next 1-year time period is forecast to be $625.25 according to 16 Wall Street analysts, 15 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is SNPS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Synopsys is a Buy. 15 of 16 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SNPS?
You can purchase shares of Synopsys via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Synopsys shares.
-
What Is The Synopsys Share Price Today?
Synopsys was last trading at $448.10 per share. This represents the most recent stock quote for Synopsys. Yesterday, Synopsys closed at $453.51 per share.
-
How To Buy Synopsys Stock Online?
In order to purchase Synopsys stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
